Serum levels of cystatin C in elderly lung cancer patients

Oncology Letters

Volumn 3, Issue 2, 2012, Pages 303-306

  Ohara, Gen ^a,b   Miyazaki, Kunihiko ^b   Kurishima, Koichi ^b   Kagohashi, Katsunori ^a   Ishikawa, Hiroichi ^c   Satoh, Hiroaki ^a   Hizawa, Nobuyuki ^b  

^a NATIONAL HOSPITAL ORGANIZATION MITO MEDICAL CENTER   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

^c Division of Respiratory Medicine   (Japan)

Author keywords

Cystatin C; Elderly; Lung cancer

Indexed keywords

C REACTIVE PROTEIN; CREATININE; CYSTATIN C;

ADULT; AGED; AGING; ARTICLE; BODY MASS; CANCER PATIENT; CLINICAL ARTICLE; CLINICAL EVALUATION; CLINICAL PRACTICE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; HUMAN; KIDNEY FAILURE; KIDNEY FUNCTION; LUNG CANCER; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MALE; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY;

EID: 84855242112     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2011.377     Document Type: Article

References (27)

1. Randers E and Erlandsen EJ: Serum cystatin C as an endogenous marker of the renal function - a review. Clin Chem Lab Med 37: 389-395, 1999.
2. Finney H, Bates CJ and Price CP: Plasma cystatin C determinations in healthy elderly population. Arch Gerontol Geriatr 29: 75-94, 1999.
3. Fliser D and Ritz E: Serum cystatin C concentration as a marker of renal dysfunction in the elderly. Am J Kidney Dis 37: 79-83, 2001.
4. Goldberg TH and Finkelstein MS: Difficulties in estimating glomerular filtration rate in the elderly. Arch Intern Med 147: 1430-1433, 1987.
5. Friedman JR, Norman DC and Yoshikawa TT: Correlation of estimated renal function parameters versus 24-hour creatinine clearance in ambulatory elderly. J Am Geriatr Soc 37: 145-149, 1989.
6. Van Pottelbergh G, Van Heden L, Matheï C and Degryse J: Methods to evaluate renal function in elderly patients: a systematic literature review. Age Ageing 39: 542-548, 2010.
7. Simonsen O, Grubb A and Thysell H: The blood serum concentration of cystatin C (c trace) as a measure of the glomerular filtration rate. Scand J Clin Lab Invest 45: 97-101, 1985.
8. Grubb A, Simonsen O, Sturtfelt G, Truedson L and Thysell H: Serum concentration of cystatin C, factor D and β2-microglobulin as a measure of glomerular filtration rate. Acta Med Scand 218: 499-503, 1985.
9. Keller CR, Odden MC, Fried LF, et al: Kidney function and markers of inflammation in elderly persons without chronic kidney disease: the health, aging, and body composition study. Kidney Int 71: 239-244, 2007.
10. Singh D, Whooley MA, Ix JH, Ali S and Shlipak MG: Association of cystatin C and estimated GFR with inflammatory biomarkers: the Heart and Soul Study. Nephrol Dial Transplant 22: 1087-1092, 2007.
11. Kos J, Krasovec M, Cimerman N, Nielsen HJ, Christensen IJ and Brünner N: Cysteine proteinase inhibitors stefin A, stefin B, and cystatin C in sera from patients with colorectal cancer: relation to prognosis. Clin Cancer Res 6: 505-511, 2000.
12. Kos J, Stabuc B, Schweigen A, et al: Cathepsins B, H, and L and their inhibitors stefin A and cystatin C in sera of melanoma patients. Clin Cancer Res 3: 1815-1822, 1997.
13. Bodnar L, Wcislo GB, Smoter M, et al: Cystatin C as a parameter of glomerular filtration rate in patients with ovarian cancer. Kidney Blood Press Res 33: 360-367, 2010.
14. Newman DJ, Thakkar H, Edwards RG, et al: Serum cystatin C measured by automated immunoassay: a more sensitive marker of changes in GFR than serum creatinine. Kidney Int 47: 312-318, 1995.
15. Stabuc B, Vrhovec L, Stabuc-Silih M and Cizej TE: Improved prediction of decreased creatinine clearance by serum cystatin C: use in cancer patients before and during chemotherapy. Clin Chem 46: 193-197, 2000.
16. Naumnik W, Niklińska W, Ossolińska M and Chyczewska E: Serum cathepsin K and cystatin C concentration in patients with advanced non-small-cell lung cancer during chemotherapy. Folia Histochem Cytobiol 47: 207-213, 2009.
17. Lababede O, Meziane M and Rice T: Seventh edition of the cancer staging manual and stage grouping of lung cancer: quick reference chart and diagrams. Chest 139: 183-189, 2011.
18. Satoh H, Kurishima K, Nakamura R, et al: Lung cancer in patients aged 80 years and over. Lung Cancer 65: 112-118, 2009.
19. Tanaka M, Matsuo K, Enomoto M and Mizuno K: A sol particle homogeneous immunoassay for measuring serum cystatin C. Clin Biochem 37: 27-35, 2004.
20. Coll E, Botey A, Alvarez L, et al: Serum cystatin C as a new marker for noninvasive measurement of glomerular filtration rate and as a marker for early renal impairment. Am J Kidney Dis 36: 29-34, 2000.
21. Ognibene A, Mannucci E, Caldini A, et al: Cystatin C reference values and aging. Clin Biochem 39: 658-661, 2006.
22. Van Den Noortgate NJ, Janssens WH, Delanghe JR, Afschrift MB and Lameire NH: Serum cystatin C concentration compared with other markers of glomerular filtration rate in the old old. J Am Geriatr Soc 50: 1278-1282, 2002.
23. Reed CH: Diagnostic applications of cystatin C. Br J Biomed Sci 57: 323-329, 2000.
24. Curhan G: Cystatin C: a marker of renal function or something more. Clin Chem 51: 293-294, 2005.
25. Knight EL, Verhave JC, Spiegelman D, et al: Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. Kidney Int 65: 1416-1421, 2004.
26. Grubb A, Björk J, Nyman U, et al: Cystatin C, a marker for successful aging and glomerular filtration rate, is not influenced by inflammation. Scand J Clin Lab Invest 71: 145-149, 2011.
27. Sloane BF: Suicidal tumor proteases. Nat Biotechnol 14: 826-827, 1996.